Taiwan Biotech Co, Ltd

Form 483 issued September 20, 2022 · Taoyuan City, Taiwan

Inspection
Sep 12 – Sep 20, 2022
Investigator
Wayne D. McGrath
Observations
2
Pages
4
FEI number
3003598505

In short: On September 20, 2022, FDA issued a Form 483 with 2 observations to Taiwan Biotech Co, Ltd in Taoyuan City, Taiwan (FEI 3003598505) after an inspection that ran Sep 12 – Sep 20, 2022. The investigator was Wayne D. McGrath. Most observations concern quality system and laboratory controls; the most-cited regulation is 21 CFR 211.22 (responsibilities of quality control unit).

At a glance

Quality system and laboratory controls account for 2 of 2 observations.

Quality system1
Laboratory controls1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    The responsibilities and procedures applicable to the quality control unit are not in…

  2. 02

    Results of stability testing are not used in determining appropriate storage…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Taiwan Biotech Co, Ltd?

FDA listed 2 observations on this Form 483, mostly about quality system and laboratory controls. The most-cited regulation is 21 CFR 211.22 (responsibilities of quality control unit). The opening words of each observation are shown on this page.

Who inspected Taiwan Biotech Co, Ltd?

Wayne D. McGrath is named on this Form 483, for the inspection of Sep 12 – Sep 20, 2022. Each investigator has a profile showing what they cite most.

When was Taiwan Biotech Co, Ltd inspected by FDA?

The inspection ran Sep 12 – Sep 20, 2022, and the Form 483 is dated September 20, 2022.

How do I get the full Form 483 for Taiwan Biotech Co, Ltd?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free